Health event prompts GAMCO succession move at Gabelli Dividend & Income Trust (GDV)

Filing Impact

(Moderate)

Filing Sentiment

(Neutral)

Form Type

8-K

Rhea-AI Filing Summary

The Gabelli Dividend & Income Trust reports that Mario J. Gabelli, its Trustee, Chairman and Chief Investment Officer, was admitted to the hospital after a medical incident on March 19, 2026, and that his condition is improving, though his return date is not yet known.

GAMCO Investors, Inc., parent of the Fund’s adviser, implemented a long-standing succession plan on March 22, 2026, naming Christopher J. Marangi as President of GAMCO. Day-to-day operations at GAMCO will be led by co-CEO Douglas R. Jamieson and Christopher J. Marangi, and the Gabelli Value team Co-Chief Investment Officers Kevin V. Dreyer and Mr. Marangi are leading portfolio management for the Fund during Mr. Gabelli’s absence.

Insights

Health-driven succession plan activated, portfolio leadership reassigned but framework remains in place.

The update explains that Mario J. Gabelli is recovering from a March 19, 2026 medical incident, while his return date is undetermined. This matters because he has been a central investment figure for the Fund and its adviser.

GAMCO activated a succession plan that had been in place for several years, elevating Christopher J. Marangi to President of GAMCO on March 22, 2026. Operational leadership rests with co-CEO Douglas R. Jamieson and Mr. Marangi, and the Gabelli Value team Co-CIOs Dreyer and Marangi lead portfolio management for the Fund.

The filing emphasizes continuity: the management structure, value-investing team, and advisory platform remain intact. The Fund also incorporates this information by reference into its effective registration statement, aligning disclosure across its regulatory documents without altering stated financial terms.

8-K Event Classification

2 items: 8.01, 9.01

2 items

Item 8.01 Other Events Other

Voluntary disclosure of events the company deems important to shareholders but not covered by other items.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, and exhibit attachments filed with this report.

Key Figures

Medical incident date: March 19, 2026 Succession plan activation date: March 22, 2026 8-K reporting date: May 7, 2026

3 metrics

Medical incident date March 19, 2026 Date of Mario J. Gabelli’s medical incident in New York City

Succession plan activation date March 22, 2026 Date GAMCO implemented its succession plan and named Marangi President

8-K reporting date May 7, 2026 Date of the current report by The Gabelli Dividend & Income Trust

Key Terms

succession plan, Chief Investment Officer, Registration Statement, emerging growth company

4 terms

succession plan financial

"GAMCO, the parent company of the Fund’s adviser... implemented GAMCO’s succession plan that has been in place for several years."

Chief Investment Officer financial

"Mario J. Gabelli (“Mr. Gabelli”),Trustee, Chairman and Chief Investment Officer of the Fund..."

A chief investment officer (CIO) is the person responsible for managing a company or organization’s investments and financial strategies. They make key decisions about where to put money to help grow wealth or achieve financial goals, much like a coach plans a team’s game strategy. Their work matters to investors because it influences how effectively an organization’s assets are used to generate returns.

Registration Statement regulatory

"The Fund incorporates the information included in this Item 8.01 by reference into its effective Registration Statement."

A registration statement is a formal document that companies file with a government agency to offer new shares of stock to the public. It provides essential information about the company's finances, operations, and risks, helping investors make informed decisions. Think of it as a detailed product description that ensures transparency and trust before buying into a company.

emerging growth company regulatory

"405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company"

An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.

Understanding 8-K Material Events →

05/07/2026 - 05:06 PM

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) May 7, 2026

The Gabelli Dividend & Income Trust

(Exact name of registrant as specified in its charter)

Delaware

811-21423

80-0080998

(State or other jurisdiction

of incorporation)

(Commission

File Number)

(IRS Employer

Identification No.)

One Corporate Center, Rye, New York		10580
(Address of principal executive offices)		(Zip Code)

Registrants telephone number, including area code (800) 422-3554

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

	☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
	☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
	☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
	☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Shares of Beneficial Interest	GDV	New York Stock Exchange
Series H Cumulative Preferred Shares	GDV Pr H	New York Stock Exchange
Series K Cumulative Preferred Shares	GDV Pr K	New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

☐ Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 8.01.

Other Events

As previously announced by GAMCO Investors, Inc. (“GAMCO”) on March 23, 2026, Mario J. Gabelli (“Mr. Gabelli”),Trustee, Chairman and Chief Investment Officer of the Fund, and Chairman, Co-Chief Executive Officer, and Chief Investment Officer – Value Portfolios of GAMCO Investors, Inc. and Chief Investment Officer – Value Portfolios of Gabelli Funds, LLC and GAMCO Asset Management, Inc., was admitted to the hospital for observation and testing after a medical incident March 19, 2026, following a busy day of events around New York City. His condition is improving and he is on the road to recovery, but the timeline for his return is not yet known.

On March 22, 2026, GAMCO, the parent company of the Fund’s adviser, Gabelli Funds, LLC (the “Adviser”), implemented GAMCO’s succession plan that has been in place for several years. In accordance with that plan, Christopher J. Marangi was named President of GAMCO on March 22, 2026.

While the timeline for Mr. Gabelli’s return remains undetermined, the day-to-day operations of GAMCO will continue to be led by co-CEO, Douglas R. Jamieson, and Christopher J. Marangi.

The Gabelli Value team Co-Chief Investment Officers Kevin V. Dreyer and Christopher J. Marangi lead the portfolio management team for the Fund during Mr. Gabelli’s absence.

The Fund incorporates the information included in this Item 8.01 by reference into its effective Registration Statement.

Item 9.01

Financial Statements and Exhibits.

(d)

Exhibits

104

Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	THE GABELLI DIVIDEND & INCOME TRUST

Date: May 7, 2026	By:	/s/ John C. Ball
	Name:	John C. Ball
	Title:	President and Treasurer

Source: View Original Filing on SEC EDGAR

FAQ

What health update about Mario J. Gabelli does GDV provide in this 8-K?

The filing states Mario J. Gabelli experienced a medical incident on March 19, 2026 and was admitted to the hospital for observation and testing. His condition is described as improving and he is on the road to recovery, though his return timeline remains undetermined.

How does the Gabelli Dividend & Income Trust (GDV) describe leadership continuity at GAMCO?

The document explains that GAMCO’s day-to-day operations will continue to be led by co-CEO Douglas R. Jamieson and Christopher J. Marangi. This arrangement follows the activation of GAMCO’s long-standing succession plan after Mr. Gabelli’s medical incident in March 2026.

What succession plan changes affecting GDV’s adviser are disclosed?

On March 22, 2026, GAMCO implemented its established succession plan and named Christopher J. Marangi as President of GAMCO. This plan was already in place for several years and was activated after Mario J. Gabelli’s medical incident to support leadership continuity at the adviser.

Who is managing the Gabelli Dividend & Income Trust portfolio during Mr. Gabelli’s absence?

The filing states that Gabelli Value team Co-Chief Investment Officers Kevin V. Dreyer and Christopher J. Marangi lead the portfolio management team for the Fund. They assume this responsibility while Mario J. Gabelli, the Fund’s Chief Investment Officer, recovers from his March 19, 2026 medical incident.

How does this GDV filing treat the disclosed information in relation to its Registration Statement?

The Fund states that the information in this Item 8.01 is incorporated by reference into its effective Registration Statement. This means the leadership and health-related disclosures become part of the Fund’s broader offering and regulatory disclosure package without changing the underlying terms described there.

What role does Christopher J. Marangi play for GAMCO and GDV after March 22, 2026?

According to the filing, Christopher J. Marangi was named President of GAMCO on March 22, 2026 and shares leadership of day-to-day operations with co-CEO Douglas R. Jamieson. He also serves as a Gabelli Value team Co-Chief Investment Officer, helping lead portfolio management for the Fund.

Filing Exhibits & Attachments

4 documents

Health event prompts GAMCO succession move at Gabelli Dividend & Income Trust (GDV)

Rhea-AI Filing Summary

Positive

Negative